Literature DB >> 21906413

M-protein gene-type distribution and hyaluronic acid capsule in group A Streptococcus clinical isolates in Chile: association of emm gene markers with csrR alleles.

A Wozniak1, P Rojas, C Rodríguez, A Undabarrena, C Garate, I Riedel, J C Román, A M Kalergis, P García.   

Abstract

Streptococcus pyogenes causes a variety of infections because of virulence factors such as capsular hyaluronic acid and M protein. The aim of this study was to determine emm types and capsule phenotype in 110 isolates of S. pyogenes from patients with invasive (sterile sites) and non-invasive (mainly pharyngitis) infections in Chile, and the relationship between both virulence factors. The most abundant types found were emm12, emm1, emm4 and emm28 and their distribution was similar to that seen in Latin America and developed countries, but very different from that in Asia and Pacific Island countries. Ten of 16 emm types identified in pharyngeal isolates were found in sterile-site isolates, and three of nine emm types of sterile-site isolates occurred in pharyngeal isolates; three emm subtypes were novel. The amount of hyaluronic acid was significantly higher in sterile-site isolates but did not differ substantially among emm types. Only three isolates were markedly capsulate and two of them had mutations in the csrR gene that codes for a repressor of capsule synthesis genes. We found a non-random association between emm types and csrR gene alleles suggesting that horizontal gene transfer is not freely occurring in the population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21906413     DOI: 10.1017/S0950268811001889

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  4 in total

1.  Protective immunity induced by an intranasal multivalent vaccine comprising 10 Lactococcus lactis strains expressing highly prevalent M-protein antigens derived from Group A Streptococcus.

Authors:  Aniela Wozniak; Natalia Scioscia; Patricia C García; James B Dale; Braulio A Paillavil; Paulette Legarraga; Francisco J Salazar-Echegarai; Susan M Bueno; Alexis M Kalergis
Journal:  Microbiol Immunol       Date:  2018-06-11       Impact factor: 1.955

2.  A novel live vector group A streptococcal emm type 9 vaccine delivered intranasally protects mice against challenge infection with emm type 9 group A streptococci.

Authors:  Aniela Wozniak; Patricia García; Enrique A Geoffroy; Daniel B Aguirre; Samantha A González; Victoria A Sarno; James B Dale; Francisco J Salazar-Echegarai; Andrea Vera; Susan M Bueno; Alexis M Kalergis
Journal:  Clin Vaccine Immunol       Date:  2014-07-23

3.  Evaluation of emm gene types, toxin gene profiles and clonal relatedness of group A streptococci.

Authors:  Firat Zafer Mengeloglu; Elif Aktas; Baris Otlu; Füsun Cömert; Canan Külah; Ebru Tas; Vildan Sümbüloglu
Journal:  Bosn J Basic Med Sci       Date:  2013-08       Impact factor: 3.363

Review 4.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.